Blood Glucose Variations and Clinical Experience with Glibenclamide in Diabetes Mellitus
Authors:
- D. J. O'SUllivanDOD. J. O'SUllivan
- W. F. CashmanWCW. F. Cashman
Abstract
Thirty patients were treated with glibenclamide for periods up to 16 months. The drug is a potent hypoglycaemic agent, and taken in a single daily dose controls blood glucose levels over a 24-hour period in maturity onset diabetes. A definite dose-effect relationship exists, and the drug may be used in doses of 5 to 20 mg. daily. There were no appreciable side-effects or toxic effects during the period of study.Keywords
This publication has 3 references indexed in Scilit:
- Klinische Untersuchungen zur Wirksamkeit des neuen oralen Antidiabetikums Glybenclamid (HB 419)DMW - Deutsche Medizinische Wochenschrift, 1969
- Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*Journal of Clinical Investigation, 1967
- [A new highly-active oral antidiabetic].1966